Detalhe da pesquisa
1.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029412
2.
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Am J Obstet Gynecol
; 227(1): 61.e1-61.e18, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216968
3.
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
Cancer
; 119(3): 586-92, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915053
4.
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses.
J Immunother Cancer
; 6(1): 19, 2018 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29510745
5.
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
Clin Cancer Res
; 12(4): 1137-43, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16489066
6.
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
J Clin Oncol
; 23(31): 8057-64, 2005 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16258104
7.
Prognostic significance of microscopic tumor burden in sentinel lymph node in patients with cutaneous melanoma.
Anticancer Res
; 35(1): 301-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25550564
8.
Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.
Cancer Biother Radiopharm
; 30(5): 187-94, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26083950
9.
Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma.
J Immunother
; 35(8): 641-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22996370
10.
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
Clin Cancer Res
; 16(8): 2402-8, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371696
11.
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
J Clin Oncol
; 24(19): 3157-63, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16809738